Literature DB >> 263305

A direct microassay for aldosterone in plasma extracts.

J Sancho, E Haber.   

Abstract

We previously described an RIA for aldosterone based on highly specific antibodies elicited with aldosterone-3,20 dioxime bovine gamma-globulin (Poulsen, K. J. Sancho, and E. Haber, Clin Immunol Immunopathol 2: 373, 1974). We now report the development of higher affinity antibodies of similar specificity that allow the direct measurement of normal aldosterone concentrations in extracts of 100 microliters plasma. The detection limit at +/- 2 SD of mean zero value was 0.2-0.3 pg. The assay was validated by 1) zero values in adrenalectomized plasma, 2) parallel displacement plots of aldosterone standards and plasma extracts, 3) 97.7 +/- 2.5% recovery of added tracer, 4) a correlation coefficient of 0.992 and a slope of 1.08 in a plot of added vs. recovered unlabeled aldosterone, 5) 10.2% interassay variation and 5.6% intraassay variation, and 6)failure of high concentrations of a variety of steroids added to plasma to perturb the measured aldosterone concentration. The simplicity of the assay results in a high degree of productivity, in that 195 plasma samples may be processed in duplicate, in addition to standard curves, in a single working day.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263305     DOI: 10.1210/jcem-47-2-391

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.

Authors:  Paul M McKie; Alessandro Cataliotti; Guido Boerrigter; Horng H Chen; S Jeson Sangaralingham; Fernando L Martin; Tomoko Ichiki; John C Burnett
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

2.  Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen.

Authors:  S Jeson Sangaralingham; Bing H Wang; Li Huang; Sirinart Kumfu; Tomoko Ichiki; Henry Krum; John C Burnett
Journal:  Peptides       Date:  2016-01-13       Impact factor: 3.750

3.  Interference by ranitidine with aldosterone secretion in vivo.

Authors:  J M Sancho; R Garcia Robles; E Mancheño; C Paya; J L Rodicio; L Ruilope
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.

Authors:  T L Stevens; J C Burnett; M Kinoshita; Y Matsuda; M M Redfield
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

5.  A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.

Authors:  Paul M McKie; Alessandro Cataliotti; Brenda K Huntley; Fernando L Martin; Timothy M Olson; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2009-09-08       Impact factor: 24.094

6.  Aldosterone and plasma renin activity in hyperthyroid rats: effects of propranolol and propylthiouracil.

Authors:  M Montiel; E Jiménez; J A Naváez; M Morell
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

7.  Aldosterone 18-glucuronide excretion determined with and without chromatography in human hypertensives.

Authors:  S Hassan-Ali; H Witzgall
Journal:  Klin Wochenschr       Date:  1979-10-15

8.  M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.

Authors:  Paul M McKie; Alessandro Cataliotti; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal:  J Am Heart Assoc       Date:  2014-01-02       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.